Investors may doubt the company's ability to improve sluggish revenue, despite a superior outlook. Market hesitation could be due to priced-in risks, though a share price plunge seems unlikely given high growth forecasts.
Gainers: In reaction to earnings/guidance: •$オフィス・デポ(ODP.US)$+8.03% (The ODP Corporation gains on guiding Q2 and FY22 earnings above the consensus; to buyback shares of $600M) •$シンクロニー・ファイナンシャル(SYF.US)$+4.2%(The financial services company posted adjusted earnings per share of $1.60 for the June ended quarter, beating analysts' estimates of $1.41 per share, according to FactSet.) •$ゴールドマン・サックス・グループ(GS.US)$+4.2% (Goldman Sachs beats...
$エイピックス・メディカル(APYX.US)$ - Apyx Medical Stock Gains Following FDA Clearance of Renuvion Dermal Handpiece for Wrinkle Reduction. Breaking above $6. Next level to break is $7 $ブラックスカイ・テクノロジー(BKSY.US)$ - BlackSky Wins 10-Year Electro Optical Commercial Layer Contract With US Gov't.,Stock needs to break $3 to continue higher $JEクリーンテック・ホールディングズ(JCSE.US)$ - Stock recent runner breaking higher. Back above IPO price. Adding above $15.50 $ノードストローム(JWN.US)$ - CO...
2
2
報告
RWJY CCJM :
Just curious, will it fly after $3 for BKSY
JESSE JAMES8832スレ主 : bottom watch
zainong : How come ah